- Home
- TNGX vs BRBI Comparison
TNGX vs BRBI Comparison
Compare TNGX & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BRBI
- Stock Information
- Founded
- TNGX 2014
- BRBI 2009
- Country
- TNGX United States
- BRBI Brazil
- Employees
- TNGX N/A
- BRBI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BRBI Finance: Consumer Services
- Sector
- TNGX Health Care
- BRBI Finance
- Exchange
- TNGX Nasdaq
- BRBI Nasdaq
- Market Cap
- TNGX 1.0B
- BRBI 1.1B
- IPO Year
- TNGX N/A
- BRBI N/A
- Fundamental
- Price
- TNGX $7.99
- BRBI $14.98
- Analyst Decision
- TNGX Strong Buy
- BRBI
- Analyst Count
- TNGX 6
- BRBI 0
- Target Price
- TNGX $10.80
- BRBI N/A
- AVG Volume (30 Days)
- TNGX 4.3M
- BRBI 21.2K
- Earning Date
- TNGX 11-04-2025
- BRBI 11-07-2025
- Dividend Yield
- TNGX N/A
- BRBI N/A
- EPS Growth
- TNGX N/A
- BRBI N/A
- EPS
- TNGX N/A
- BRBI 0.12
- Revenue
- TNGX $66,501,000.00
- BRBI N/A
- Revenue This Year
- TNGX $20.41
- BRBI N/A
- Revenue Next Year
- TNGX N/A
- BRBI $29.31
- P/E Ratio
- TNGX N/A
- BRBI $12.18
- Revenue Growth
- TNGX 53.29
- BRBI N/A
- 52 Week Low
- TNGX $1.03
- BRBI $12.15
- 52 Week High
- TNGX $9.70
- BRBI $67.01
- Technical
- Relative Strength Index (RSI)
- TNGX 49.39
- BRBI N/A
- Support Level
- TNGX $7.12
- BRBI N/A
- Resistance Level
- TNGX $8.17
- BRBI N/A
- Average True Range (ATR)
- TNGX 0.74
- BRBI 0.00
- MACD
- TNGX -0.07
- BRBI 0.00
- Stochastic Oscillator
- TNGX 45.74
- BRBI 0.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.